Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM | NSE
185.66
INR1.63
0.89%
JAGSNPHARM | NSE
Loading StockChartView...
About Jagsonpal Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
185.66
Open
185.80
High
186.90
Low
184.00
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health pain and analgesics and general medicine. It offers general medicines such as allergy management immunity and cell protection gut and mind management anti-infectives and dentist and ENT range products; and women's healthcare products including pregnancy care and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management and bone and joint care. It offers drugs in the form of tablets capsules and syrups. The company was founded in 1964 and is headquartered in New Delhi India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
View LessJAGSNPHARM | NSE
Risk
37.4
Sharpe
-0.47
Luna's Score
49/100
Recommendation
Hold
Luna says (JAGSNPHARM | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
18.0%1 month
37.4%3 months
38.9%6 months
35.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
61.65
Fwd. PE
-
Price to book
6.69
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
34.57
Ent. to rev.
5.35
PEG
-
Other Fundamentals
EBITDA
241.98M
MarketCap
4.93B
MarketCap(USD)
52.86M
Div. yield
1.06
Op. margin
14.92
Erngs. growth
-32.30
Rev. growth
2.10
Ret. on equity
12.97
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
10.45
Range1M
43.95
Range3M
46.50
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.36
Price X volume
23.30M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 34.57 | 24.85 | Expensive |
| Ent. to Revenue | 5.35 | 11.40 | Cheaper |
| PE Ratio | 61.65 | 51.36 | Expensive |
| Price to Book | 6.69 | 6.83 | Par |
| Dividend Yield | 1.06 | 0.52 | Leader |
| Std. Deviation (3M) | 38.85 | 42.17 | Par |
| Debt to Equity | 0.05 | 0.35 | Cheaper |
| Debt to Assets | 0.04 | 0.17 | Cheaper |
| Market Cap | 4.93B | 290.82B | Emerging |
